Literature DB >> 26279439

MiR-499-5p Contributes to Hepatic Insulin Resistance by Suppressing PTEN.

Lei Wang1, Ning Zhang, Hua-Ping Pan, Zun Wang, Zhen-Yu Cao.   

Abstract

BACKGROUND: Type 2 diabetes afflicts 95% of diabetes patients. Recent data suggest that miRNAs play a key role in insulin production, secretion and function. This study aims to explore the specific role of miR-499-5p in hepatic insulin resistance.
METHODS: The miRNA expression levels in the livers of db/db mice were analyzed using miRNA chips and were verified by real-time PCR. miR-499-5p mimics and an inhibitor were transfected into NCTC1469 cells. Then, the PI3K/AKT signaling pathway and glycogen level were determined. The target genes of miR-499-5p were predicted by bioinformatics and then confirmed by dual luciferase reporter assay and Western blot. To establish an insulin resistance (IR) animal model, C57BL/6 mice were fed a high-fat diet (HFD). The level of miR-499-5p in the livers of HFD-fed mice was upregulated through tail vein injection of adenovirus vectors (ad) containing miR-499-5p mimics. The glucose tolerance test (GTT) and insulin tolerance test (ITT) were used to determine glucose tolerance and insulin tolerance, respectively.
RESULTS: MicroRNA chips and qPCR showed that miR-499-5p was significantly decreased in the livers of db/db mice. Downregulation of miR-499-5p impaired the insulin signaling pathway and glycogen synthesis, whereas upregulation of miR-499-5p promoted the insulin signaling pathway and glycogen synthesis in NCTC1469 cells. The dual luciferase reporter assay and Western blot demonstrated that PTEN was the target gene of miR-499-5p. Compared with the control group, miR-499-5p was increased 2.1-fold in the livers of HFD-fed mice. By tail vein injection of adenovirus vector containing miR-499-5p mimics, GTT and ITT were improved in HFD-fed mice.
CONCLUSION: Downregulation of the miR-499-5p level impaired the PI3K/AKT/GSK signaling pathway and glycogen synthesis by targeting PTEN.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26279439     DOI: 10.1159/000430198

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  12 in total

1.  Identification of microRNAs regulating Escherichia coli F18 infection in Meishan weaned piglets.

Authors:  Zhengchang Wu; Weiyun Qin; Seng Wu; Guoqiang Zhu; Wenbin Bao; Shenglong Wu
Journal:  Biol Direct       Date:  2016-11-03       Impact factor: 4.540

Review 2.  MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Authors:  Zhiqiang Fang; Guorui Dou; Lin Wang
Journal:  Int J Biol Sci       Date:  2021-04-29       Impact factor: 6.580

Review 3.  Regulatory Roles of MicroRNAs in Diabetes.

Authors:  Juan Feng; Wanli Xing; Lan Xie
Journal:  Int J Mol Sci       Date:  2016-10-17       Impact factor: 5.923

4.  A Meta-Analysis of miR-499 rs3746444 Polymorphism for Cancer Risk of Different Systems: Evidence From 65 Case-Control Studies.

Authors:  Xianglin Yang; Xuelian Li; Baosen Zhou
Journal:  Front Physiol       Date:  2018-06-12       Impact factor: 4.566

5.  MicroRNA-499a (rs3746444A/G) gene variant and susceptibility to type 2 diabetes-associated end-stage renal disease.

Authors:  Manal S Fawzy; Essam Al Ageeli; Saeed Awad Al-Qahtani; Baraah T Abu Alsel; Shahad W Kattan; Walla Alelwani; Eman A Toraih
Journal:  Exp Ther Med       Date:  2021-11-22       Impact factor: 2.447

Review 6.  SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes.

Authors:  Yogita Chhichholiya; Aman Kumar Suryan; Prabhat Suman; Anjana Munshi; Sandeep Singh
Journal:  Front Genet       Date:  2021-12-01       Impact factor: 4.599

7.  miRNA-15a, miRNA-15b, and miRNA-499 are Reduced in Erythrocytes of Pre-Diabetic African-American Adults.

Authors:  Maurice B Fluitt; Namita Kumari; Gail Nunlee-Bland; Sergei Nekhai; Kanwal K Gambhir
Journal:  Jacobs J Diabetes Endocrinol       Date:  2016-11-15

8.  Hyperoside Protects HK-2 Cells Against High Glucose-Induced Apoptosis and Inflammation via the miR-499a-5p/NRIP1 Pathway.

Authors:  Jingbo Zhou; Shu Zhang; Xinyi Sun; Yan Lou; Jiangyi Yu
Journal:  Pathol Oncol Res       Date:  2021-04-14       Impact factor: 3.201

Review 9.  Non-Coding RNAs as Potential Novel Biomarkers for Early Diagnosis of Hepatic Insulin Resistance.

Authors:  Ariadna Pielok; Krzysztof Marycz
Journal:  Int J Mol Sci       Date:  2020-06-11       Impact factor: 5.923

Review 10.  Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management.

Authors:  Tiange Chi; Jiaran Lin; Mina Wang; Yihan Zhao; Zehuan Liao; Peng Wei
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.